Camlipixant
Camlipixant is an investigational new drug that is being evaluated for the treatment of chronic cough. It is a P2X3 receptor antagonist. See also * gefapixant Gefapixant, sold under the brand name Lyfnua, is a medication used to treat chronic (long-term) cough. It acts as an antagonist of the P2RX3 receptor. It was authorized for medical use in the European Union in September 2023. Medical uses ... References Benzamides Carbamates Morpholines Imidazopyridines {{respiratory-system-drug-stub ...
[...More Info...]       [...Related Items...]     OR:     [Wikipedia]   [Google]   [Baidu]